Home > Boards > US Listed > Biotechs > iBio, Inc. (IBIO)

from Stockwit's: Why would Tom Isett tweet a

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
JPetroInc Member Profile
 
Followed By 418
Posts 21,010
Boards Moderated 2
Alias Born 02/05/04
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/25/2020 5:11:22 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 11/25/2020 4:39:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/24/2020 7:41:08 AM
iBio Announces Issuance of U.S. Patent Covering Endostatin Peptides for Treating Fibrosis GlobeNewswire Inc. - 11/24/2020 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/16/2020 4:18:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2020 4:11:59 PM
iBio Reports Fiscal First Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 11/16/2020 4:05:00 PM
iBio to Participate in Alliance Global Partners’ Virtual Healthcare Symposium GlobeNewswire Inc. - 11/12/2020 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/6/2020 4:03:51 PM
iBio to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Update on Monday, November 16 ,2020 GlobeNewswire Inc. - 11/5/2020 4:30:00 PM
iBio Announces Appointment of Randy J. Maddux as Chief Operating Officer GlobeNewswire Inc. - 11/3/2020 7:30:00 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 10/28/2020 2:40:53 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 10/27/2020 5:01:01 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 10/23/2020 5:21:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/22/2020 4:06:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/16/2020 4:06:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2020 6:10:52 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2020 6:10:08 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2020 6:09:10 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/16/2020 6:08:32 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/16/2020 6:07:29 AM
Accomplished Financial Executive, Gary Sender, Joins iBio’s Board of Directors GlobeNewswire Inc. - 10/15/2020 4:05:10 PM
iBio Announces Appointment of Dr. Alexandra Kropotova to Board of Directors GlobeNewswire Inc. - 10/15/2020 7:30:10 AM
iBio Announces Appointment of Dr. Linda Armstrong to Board of Directors GlobeNewswire Inc. - 10/14/2020 4:05:10 PM
Annual Report (10-k) Edgar (US Regulatory) - 10/13/2020 5:19:20 PM
JPetroInc   Monday, 08/10/20 09:45:24 PM
Re: doebop post# 24358
Post # of 25308 
from Stockwit's: Why would Tom Isett tweet a picture of NVAX's COVID-19 vaccines that are kept in a tray at NVAX's labs in Maryland on March 20th? NVAX vaccine requires an immune-boosting ingredient called an 'adjuvant' to be effective.



NPR coverage here on NVAX COVID-19 vaccine work:

The Special Sauce That Makes Some Vaccines Work

August 6, 20202:29 PM ET

https://www.npr.org/sections/health-shots/2020/08/06/899813217/the-special-sauce-that-makes-some-vaccines-work?utm_campaign=storyshare&utm_source=twitter.com&utm_medium=social

____________________________________________________________

Note: Dr Corey Casper from Infectious Disease Research Institute (IDRI) is quoted in same article above...

https://www.streetinsider.com/dr/news.php?id=16727405

Quote:
That's a sentiment Corey Casper totally agrees with. He's the CEO of the Infectious Disease Research Institute and a proselytizer for adjuvant research. Casper says to consider what happened when the pharmaceutical company GlaxoSmithKline added a powerful adjuvant to a shingles vaccine.

"It took a vaccine that had previously existed which was about 50% effective, and it made it 97% effective," Casper says. "Not just in all people but in the hardest-to-protect people, which are the elderly, who typically make poor immune responses."

Casper says the vaccine community has underestimated the importance of adjuvants. He even has data suggesting that adjuvants alone might be capable of preventing infectious disease. That has enormous implications.

"Every time a new infection pops up, there's a race to develop a new vaccine for it," Casper says. "But what if you could give the adjuvant alone and you didn't have to develop a vaccine? That adjuvant could be stockpiled, it could be made at millions of doses, placed on the shelf, sitting there waiting for the next pandemic.


______________________________________________________________

Is IBIO and NVAX working together behind the scenes…?



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences